Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for patients battling severe transplant complication

NCT ID NCT06263478

Ongoing Disease control Sponsor: Incyte Biosciences Japan GK Source: ClinicalTrials.gov ↗

Summary

This study is testing a drug called axatilimab for Japanese patients with chronic graft-versus-host disease (cGVHD) that has come back or hasn't improved after at least two prior treatments. The goal is to see if the drug can reduce the severity of the disease and improve symptoms. The study will measure how well patients respond, how long the benefit lasts, and monitor for side effects.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC GRAFT VERSUS HOST DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Fujita Health University Hospital

    Aichi, 470-1192, Japan

  • Hiroshima University Hospital

    Hiroshima, 734-8551, Japan

  • Hokkaido University Hospital

    Hokkaido, 060-8648, Japan

  • Japanese Red Cross Aichi Medical Center Nagoya Daiichi Hospital

    Nagoya, 453-8511, Japan

  • Kobe City Medical Center General Hospital

    Hyōgo, 650-0047, Japan

  • Kyushu University Hospital

    Fukuoka, Japan

  • National Center For Child Health and Development

    Tokyo, 157-8535, Japan

  • National Hospital Organization Kumamoto Medical Center

    Kumamoto, 860-0008, Japan

  • Okayama University Hospital

    Okayama, 700-8558, Japan

  • Osaka Metropolitan University Hospital

    Osaka, 545-8586, Japan

  • Osaka Prefectural Hospital Organization Osaka International Cancer Institute

    Osaka, 541-8567, Japan

  • Saitama Prefectural Children'S Medical Center

    Saitama-shi, Saitama,, 330-8777, Japan

  • Tohoku University Hospital

    Miyagi, 980-8574, Japan

  • Tokai University Hospital

    Kanagawa, 259-1193, Japan

  • Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital

    Tokyo, 113-8677, Japan

  • University of Fukui Hospital

    Fukui, 910-1193, Japan

Conditions

Explore the condition pages connected to this study.

CHRONIC GRAFT VERSUS HOST DISEASE